EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Simulation-Based Validation Study of Incremental Predictive Value for Alzheimer's Disease Prediction Models

Hanshuo Pang, Yuxuan Pang

International Journal of Biology and Life Sciences · 15.11.2026 · 17 (2) · 186-193

DOI: 10.54097/4jttx317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biology and Life Sciences, online erschienen am 15.11.2026. Verfasst von Hanshuo Pang und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the leading cause of dementia worldwide, and its pathological changes often occur several years before the onset of clinical symptoms. Therefore, early identification of individuals with high risk of progression has important clinical significance for subsequent timely intervention and disease management. However, the cumulative predictive value of a single biomarker and the combined use of multiple indicators under different modeling conditions and risk scenarios is still insufficiently quantified. In this study, a Monte Carlo simulation framework was constructed based on the ADEMP (Aims,Data-generating mechanism, Estimand, Methods, Performance measures) structure to systematically evaluate the incremental contribution of four plasma biomarkers (GFAP, pTau181, pTau217 and Aβ42 / 40) to AD risk prediction. We generated survival data covering a variety of scenarios, including demographic variables, cognitive assessment scores, and biomarker measurements. The Cox proportional hazards model was used in the analysis. The basic model was compared with the extended enhanced model with biomarkers, and the predictive performance was evaluated by C index, ΔC index, ΔR2, IDI, risk stratification analysis and sensitivity test. The results showed that GFAP and pTau217 were the most prominent in independent prediction, and the improvement of prediction effect was the most significant when the four markers were combined. This incremental effect remains stable under different sample sizes and censoring rates, indicating that the conclusion has strong robustness. The above findings provide strong support for integrating plasma biomarkers into traditional AD prediction models, and also build a reference methodological framework for future preclinical evaluation of the value of new biomarkers. There are some limitations in this study. It uses simulated data rather than real clinical cases, which cannot fully reflect the heterogeneity and complexity of patient data in the real world. Future research should conduct external validation of the above results, and further explore more flexible models such as adaptive ensemble estimation, in order to ultimately achieve truly personalized AD risk assessment.

Zitieren

APA

Pang, H., & Pang, Y. (2026). A Simulation-Based Validation Study of Incremental Predictive Value for Alzheimer's Disease Prediction Models. International Journal of Biology and Life Sciences, 17(2), 186-193. https://doi.org/10.54097/4jttx317

Vancouver

Pang H, Pang Y. A Simulation-Based Validation Study of Incremental Predictive Value for Alzheimer's Disease Prediction Models. International Journal of Biology and Life Sciences. 2026;17(2):186-193. doi:10.54097/4jttx317

BibTeX
@article{Pang2026,
  author = {Pang, Hanshuo and Pang, Yuxuan},
  title = {A Simulation-Based Validation Study of Incremental Predictive Value for Alzheimer's Disease Prediction Models},
  journal = {International Journal of Biology and Life Sciences},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {186--193},
  doi = {10.54097/4jttx317}
}
Kostenlos starten →